Validation of an Allergic Rhinitis Control Test in Children

Recruiting N/A Interventional Study
Allergic Rhinitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 – 11
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
135 (estimated)
Sponsor
University Hospital, Montpellier · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in te…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis * Parents formulated their study participation agreement by signing the consent form. Exclusion Criteria: * Patients that are already treated for the actual episode of allergic rhinitis and a…
Contacts

Pascal DEMOLY, Professor

+334 67 33 61 27

pascal.demoly@inserm.fr

CONTACT

Anca CHIRIAC, MD

a-chiriac@chu-montpellier.fr

CONTACT